Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1993-5-21
pubmed:abstractText
Metabotropic receptor subtypes have been proposed based on pharmacological, signal transduction and cDNA sequence data. We assessed potential metabotropic binding site subtypes with in vitro quantitative [3H]glutamate autoradiography in adult rat brains in the presence of saturating concentrations of N-methyl-D-aspartate (NMDA) and (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate (AMPA). Quisqualate (QUIS) competition curves resolved two differentially distributed binding sites (KIhigh = 17 nM; KIlow = 62 microM). Trans-1-amino-cyclopentane- 1,3-dicarboxylic acid (t-ACPD) and 1S,3R-ACPD displaced [3H]glutamate binding both in the absence and presence of a quisqualate concentration (2.5 microM) that saturates the high affinity sites, suggesting that both sites are linked to metabotropic receptors. We conclude that two metabotropic binding sites with different distributions and pharmacological profiles can be detected with selective [3H]glutamate binding assays.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/1-amino-1,3-dicarboxycyclopentane, http://linkedlifedata.com/resource/pubmed/chemical/Cycloleucine, http://linkedlifedata.com/resource/pubmed/chemical/Excitatory Amino Acid Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Glutamates, http://linkedlifedata.com/resource/pubmed/chemical/Glutamic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Ibotenic Acid, http://linkedlifedata.com/resource/pubmed/chemical/N-Methylaspartate, http://linkedlifedata.com/resource/pubmed/chemical/Quisqualic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, AMPA, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Glutamate, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Kainic Acid, http://linkedlifedata.com/resource/pubmed/chemical/alpha-Amino-3-hydroxy-5-methyl-4-iso...
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0959-4965
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
311-3
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:7682857-Animals, pubmed-meshheading:7682857-Autoradiography, pubmed-meshheading:7682857-Binding, Competitive, pubmed-meshheading:7682857-Brain Chemistry, pubmed-meshheading:7682857-Corpus Striatum, pubmed-meshheading:7682857-Cycloleucine, pubmed-meshheading:7682857-Excitatory Amino Acid Antagonists, pubmed-meshheading:7682857-Glutamates, pubmed-meshheading:7682857-Glutamic Acid, pubmed-meshheading:7682857-Ibotenic Acid, pubmed-meshheading:7682857-Male, pubmed-meshheading:7682857-N-Methylaspartate, pubmed-meshheading:7682857-Quisqualic Acid, pubmed-meshheading:7682857-Rats, pubmed-meshheading:7682857-Rats, Sprague-Dawley, pubmed-meshheading:7682857-Receptors, AMPA, pubmed-meshheading:7682857-Receptors, Glutamate, pubmed-meshheading:7682857-Receptors, Kainic Acid, pubmed-meshheading:7682857-alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
pubmed:year
1993
pubmed:articleTitle
Quisqualate resolves two distinct metabotropic [3H]glutamate binding sites.
pubmed:affiliation
Neurology Service, Massachusetts General Hospital, Boston 02114.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S.